You're Cured Till You're Not: Should Disease-Free Survival Be Used as a Regulatory or Clinical End Point for Adjuvant Therapy of Cancer?
Author:
Affiliation:
1. IRCCS Ospedale Policlinico San Martino, Medical Oncology Unit 1, Genova, Italy
2. School of Public Health, Monash University and Department of Medical Oncology, Alfred Health, Melbourne, Victoria, Australia
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.01531
Reference33 articles.
1. Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics
2. Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
3. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
4. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
5. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials;Journal of Clinical Oncology;2024-07-01
2. Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement;Current Oncology;2024-03-29
3. Endpoints for trials of adjuvant anticancer therapies;BMJ Oncology;2023-12
4. Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience;JCO Oncology Practice;2023-11-15
5. Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective;Journal of Clinical Oncology;2023-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3